54 related articles for article (PubMed ID: 16892547)
1. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of prostate cancer.
Visakorpi T
Ann Chir Gynaecol; 1999; 88(1):11-6. PubMed ID: 10230676
[TBL] [Abstract][Full Text] [Related]
5. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
Bubendorf L
Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetics of prostate cancer.
Nupponen NN; Visakorpi T
Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer metastasis-suppressor genes: a current perspective.
Yoshida BA; Chekmareva MA; Wharam JF; Kadkhodaian M; Stadler WM; Boyer A; Watabe K; Nelson JB; Rinker-Schaeffer CW
In Vivo; 1998; 12(1):49-58. PubMed ID: 9575426
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
[TBL] [Abstract][Full Text] [Related]
9. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of progression of prostate cancer.
Nupponen N; Visakorpi T
Eur Urol; 1999; 35(5-6):351-4. PubMed ID: 10325488
[TBL] [Abstract][Full Text] [Related]
11. Searching for suppressor genes in prostate cancer.
Peehl DM
Cancer Surv; 1991; 11():25-34. PubMed ID: 1668728
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
